
# BreastDCEDL - 2,070 Breast Cancer Patients

Curated deep learning-ready DCE-MRI dataset with standardized 3D NIfTI volumes, tumor segmentations, and harmonized clinical metadata from three major trials (I-SPY2, I-SPY1, Duke). Designed for reproducible research in breast cancer imaging analysis.
Deep learning-ready dataset of pretreatment 3D dynamic contrast-enhanced MRI (DCE-MRI) scans from **2,070 breast cancer patients** across three clinical trials: **I-SPY2** (n=982), **I-SPY1** (n=172), and **Duke** (n=916).


## üìÑ Publication

**BreastDCEDL: A Comprehensive Breast Cancer DCE-MRI Dataset and Transformer Implementation for Treatment Response Prediction**  
[Read on arXiv](https://doi.org/10.48550/arXiv.2506.12190)
```bibtex
@article{fridman2025breastdcedl,
  title={BreastDCEDL: A Comprehensive Breast Cancer DCE-MRI Dataset and Transformer Implementation for Treatment Response Prediction},
  author={Fridman, Naomi and Solway, Bubby and Fridman, Tomer and Barnea, Itamar and Goldstein, Anat},
  journal={arXiv preprint arXiv:2506.12190},
  year={2025},
  doi={10.48550/arXiv.2506.12190}
}
```

## üîç Dataset Versions

Both versions preserve original DICOM intensity values (converted from uint16 to float64) without any preprocessing, normalization, or manipulation. All medical data processing code is available in the dataset-specific subdirectories for full transparency.

### Dataset Characteristics

#### MinCrop Version (256√ó256√óvaried slices)
| Dataset | Patients | Avg Z-slices | Time Points | Size (GB) |
|---------|----------|--------------|-------------|-----------|
| I-SPY1 | 172 | 28 | 3 | 3.8 |
| I-SPY2 | 982 | 39 | 3 | 30.0 |
| Duke | 918 | 25 | 3 | 18.4 |
| **Total** | **2,072** | **32** | **3** | **52.2** |

#### Full Version (Original Resolution)
| Dataset | Patients | Common Resolutions | Avg Z-slices | Avg Time Points | Size (GB) |
|---------|----------|-------------------|--------------|-----------------|-----------|
| I-SPY1 | 172 | 256√ó256 (91%), 512√ó512 (9%) | 59 | 3.4 | 10.8 |
| I-SPY2 | 982 | 256√ó256 (78%), 320√ó320 (12%), other (10%) | 106 | 7.2 | 237.1 |
| Duke | 916 | 512√ó512 (68%), 448√ó448 (28%), 320√ó320 (4%) | 170 | 4.5 | 658.0 |
| **Total** | **2,070** | **Multiple (256-512)** | **131** | **5.7** | **905.9** |

#### Spatial Resolution Distribution (Full Dataset)
- **256√ó256**: 924 patients (45%)
- **320√ó320**: 86 patients (4%)
- **384√ó384**: 140 patients (7%)
- **448√ó448**: 257 patients (12%)
- **512√ó512**: 642 patients (31%)

### MinCrop Version

The MinCrop version provides the essential DCE-MRI data needed for most computational approaches, from traditional radiomics to state-of-the-art deep learning. It contains three carefully selected time points (pre-contrast, early post-contrast, late post-contrast) that radiologists use for clinical tumor assessment, cropped to 256√ó256 pixels around the main tumor. 

This standardized format supports any computational method: radiomics feature extraction, traditional machine learning classifiers, and deep learning architectures. The CSV metadata with numerically encoded clinical variables and 3D NIfTI imaging files ensure seamless compatibility with all major programming languages and medical imaging software (Python, R, MATLAB, ITK-SNAP, 3D Slicer, etc.). Repository examples demonstrate Python implementations using PyTorch and HuggingFace infrastructure for deep learning, though the data format is framework-agnostic.

The MinCrop version has been validated in published research, achieving pCR prediction AUC of 0.94 and HER2 prediction AUC of 0.74 using RGB fusion of the three time points. It provides sufficient temporal information for most clinical prediction tasks while maintaining a manageable dataset size.

- **Download**: [Zenodo](https://zenodo.org/records/15627233) (52 GB)
- **Proven applications**: RGB fusion models, radiomics pipelines, classification tasks

![DCE-MRI temporal phases](https://github.com/naomifridman/BreastDCEDL/blob/main/images/ser_images.png?raw=true)

### Full Version

The Full version preserves complete spatiotemporal information for researchers investigating advanced temporal dynamics, developing novel preprocessing methods, or requiring the full field of view. Contains all acquired time points (3-12) at original resolution, enabling deep exploration of contrast enhancement kinetics and spatial relationships beyond the tumor region.

- **I-SPY1**: [Download from Zenodo](https://zenodo.org/records/15627233)
- **I-SPY2**: [Download from Zenodo](https://zenodo.org/records/15627233)
- **Duke**: Download from [TCIA](https://www.cancerimagingarchive.net/), convert using provided code
  
## üîç Dataset Versions

### MinCrop Version

The MinCrop version provides three carefully selected DCE-MRI time points (pre-contrast, early post-contrast, late post-contrast) cropped to 256√ó256 pixels around the main tumor. This version has been successfully used to train deep learning models achieving state-of-the-art results for pCR (AUC 0.94) and HER2 (AUC 0.74) prediction in published research. 

The dataset is suitable for a wide range of computational approaches including radiomics feature extraction, traditional machine learning, and deep learning. The standardized CSV metadata format with numerically encoded clinical variables and 3D NIfTI imaging files ensures compatibility with all major programming languages and medical imaging software. Examples in this repository demonstrate implementation in Python using PyTorch and HuggingFace infrastructure, though the data format supports any computational framework.

**Key features:**
- **3 tumor-centered scans per patient**: Pre-contrast, early post-contrast, late post-contrast
- **Standardized size**: All scans cropped to 256√ó256 pixels around the main tumor
- **Fully available on Zenodo**: [Download MinCrop Dataset](https://zenodo.org/records/15627233)
- **Clinical relevance**: These three time points are specifically selected by radiologists for tumor identification, characterization, and segmentation in clinical practice

![Example of DCE-MRI temporal phases](https://github.com/naomifridman/BreastDCEDL/blob/main/images/ser_images.png?raw=true)

### Full Version

The Full version preserves the complete temporal and spatial information from the original acquisitions, containing 3-12 DCE-MRI time points per patient at original sizes. This comprehensive dataset is designed for researchers who need to explore deeper temporal dynamics, develop novel preprocessing methods, or investigate the full spatiotemporal complexity of contrast enhancement patterns.

**Important**: All imaging data is unprocessed and preserves exact DICOM values, converted from uint16 to float64 format without normalization or intensity manipulation. Complete medical data processing code is available in the dataset-specific subdirectories (I-SPY1/, I-SPY2/, DUKE/) for full transparency and reproducibility.

**Availability:**
- **I-SPY1 (Full)**: [Download from Zenodo](https://zenodo.org/records/15627233)
- **I-SPY2 (Full)**: [Download from Zenodo](https://zenodo.org/records/15627233)
- **Duke**: Download from [TCIA](https://www.cancerimagingarchive.net/) and convert using provided code
```

## üìÅ Repository Contents

| File | Description |
|------|-------------|
| `BreastDCEDL_metadata.csv` | Metadata for the full BreastDCEDL dataset |
| `BreastDCEDL_metadata_min_crop.csv` | Metadata for the MinCrop version |
| `BreastDCEDL_demo.ipynb` | Visualize data examples included in this repository |
| `BreastDCEDL_demo_on_local_data_min_crop.ipynb` | Explore and work with MinCrop data after downloading from Zenodo |
| `BreastDCEDL_vit_predict.ipynb` | Predict pCR using trained ViT model |

**Directories:** `I-SPY1/`, `I-SPY2/`, and `DUKE/` contain dataset-specific code for preprocessing metadata, DICOM exploration, and conversion to NIfTI format.


## üéØ Benchmark Tasks

Three standardized classification tasks with preserved train/validation/test splits:

| Task | Description | Distribution | Best Performance |
|------|-------------|--------------|-----------------|
| **pCR Prediction** | Pathological complete response to neoadjuvant therapy | 29.5% positive (n=428/1452) | AUC 0.94 (ViT, HR+/HER2‚àí)¬π |
| **HER2 Status** | HER2 expression | 22.1% positive (n=458/2070) | AUC 0.74 (Dual-Attention ResNet)¬≤ |
| **HR Status** | Hormone receptor positivity | 64.2% positive (n=1327/2070) | - |

¬πResults from [Fridman et al., 2025 - BreastDCEDL](https://doi.org/10.48550/arXiv.2506.12190)  
¬≤Results from [Fridman & Goldstein, 2025 - Dual-Attention ResNet](https://arxiv.org/abs/2510.13897)

### Data Splits

| Split | pCR N | pCR+ | pCR‚àí | HR N | HR+ | HR‚àí | HER2 N | HER2+ | HER2‚àí |
|-------|-------|------|------|------|-----|-----|--------|-------|-------|
| **Training** | 1099 | 322 | 777 | 1529 | 987 | 542 | 1528 | 345 | 1183 |
| **Validation** | 176 | 53 | 123 | 268 | 167 | 101 | 268 | 58 | 210 |
| **Test** | 177 | 53 | 124 | 271 | 173 | 98 | 269 | 56 | 213 |
| **Total** | 1452 | 428 | 1024 | 2068 | 1327 | 741 | 2065 | 459 | 1606 |

*N = number of patients with available labels for each biomarker

## üè• Dataset Details

### BreastDCEDL_ISPY2 (n=982)
- **Sequences**: 3-12 time points (typically 7)
- **Annotations**: Full 3D tumor segmentations at 3 selected time points
![Example from I-SPY1](https://github.com/naomifridman/BreastDCEDL/blob/main/images/spy2_example.png?raw=true)
### BreastDCEDL_ISPY1 (n=172)
- **Sequences**: 3-5 usable DCE scans
- **Annotations**: Full 3D tumor segmentations
![Example from I-SPY1](https://github.com/naomifridman/BreastDCEDL/blob/main/images/spy1_example.png?raw=true)
### Duke (n=916)
- **NAC subset**: 298 patients with pCR labels (only 31% received neoadjuvant chemotherapy)
- **Sequences**: 1 pre-contrast + 2-4 post-contrast scans
- **Annotations**: Bounding box of largest tumor (no full segmentation)
![Example from Duke](https://github.com/naomifridman/BreastDCEDL/blob/main/images/duke_example.png?raw=true)
## üöÄ Quick Start

### Option 1: Explore Sample Data (No Download Required)
Open `BreastDCEDL_demo.ipynb` to visualize and explore example data included in this repository.

[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](https://colab.research.google.com/github/naomifridman/BreastDCEDL/blob/main/BreastDCEDL_demo.ipynb)

### Option 2: Work with Full MinCrop Dataset
1. Download the MinCrop dataset from [Zenodo](https://zenodo.org/records/15627233)
2. Open `BreastDCEDL_demo_on_local_data_min_crop.ipynb`
3. Follow the notebook to explore and analyze the data

[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](https://colab.research.google.com/github/naomifridman/BreastDCEDL/blob/main/BreastDCEDL_demo_on_local_data_min_crop.ipynb)

## üî¨ Clinical Background

Dynamic Contrast-Enhanced MRI (DCE-MRI) is a key imaging technique for breast cancer evaluation. It captures tissue perfusion dynamics through sequential 3D scans before and after contrast agent administration. In breast cancer:
- **Enhancement patterns**: Malignant tumors typically show rapid initial enhancement followed by washout or plateau
- **Clinical protocol**: Radiologists analyze pre-contrast and multiple post-contrast phases (typically 3-12 time points)
- **Predictive value**: Enhancement dynamics correlate with treatment response and can predict pathological complete response (pCR) to neoadjuvant therapy

For detailed methodology, see [Fridman et al., 2025](https://doi.org/10.48550/arXiv.2506.12190)

## üìö Citations

If you use the BreastDCEDL dataset or code in your research, please cite the article:

### Article Citation (Required)
```bibtex
@article{fridman2025breastdcedl,
  title={BreastDCEDL: A Comprehensive Breast Cancer DCE-MRI Dataset and Transformer Implementation for Treatment Response Prediction},
  author={Fridman, Naomi and Solway, Bubby and Fridman, Tomer and Barnea, Itamar and Goldstein, Anat},
  journal={arXiv preprint arXiv:2506.12190},
  year={2025},
  doi={10.48550/arXiv.2506.12190}
}
```

### Dataset Citation
```bibtex
@dataset{fridman2025breastdcedl_dataset,
  author       = {Fridman, Naomi and others},
  title        = {BreastDCEDL: Curated DCE-MRI Dataset},
  year         = {2025},
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.15627233}
}
```

## üîó Resources
- **Zenodo Repository**: [https://zenodo.org/records/15627233](https://zenodo.org/records/15627233)
  
### Original Data Sources
- **I-SPY1**: Newitt, D., Hylton, N., on behalf of the I-SPY 1 Network and ACRIN 6657 Trial Team (2016). *Breast DCE-MRI Data and Segmentations from Patients in the I-SPY 1/ACRIN 6657 Trials* [Data set]. The Cancer Imaging Archive. [https://doi.org/10.7937/K9/TCIA.2016.HdHpgJLK](https://doi.org/10.7937/K9/TCIA.2016.HdHpgJLK)

- **I-SPY2**: Li, W., Newitt, D. C., Gibbs, J., Wilmes, L. J., Jones, E. F., Arasu, V. A., ... & Hylton, N. M. (2022). *I-SPY 2 Breast Dynamic Contrast Enhanced MRI Trial (ISPY2)* (Version 1) [Data set]. The Cancer Imaging Archive. [https://doi.org/10.7937/TCIA.D8Z0-9T85](https://doi.org/10.7937/TCIA.D8Z0-9T85)

- **Duke**: Saha, A., Harowicz, M. R., Grimm, L. J., Kim, C. E., Ghate, S. V., Walsh, R., & Mazurowski, M. A. (2021). *Dynamic contrast-enhanced magnetic resonance images of breast cancer patients with tumor locations (Duke-Breast-Cancer-MRI)* [Data set]. The Cancer Imaging Archive. [https://doi.org/10.7937/TCIA.e3sv-re93](https://doi.org/10.7937/TCIA.e3sv-re93)


## üìù License

Please refer to the original data sources for licensing information.
